Franklin Resources’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.3M | Sell |
402,789
-134,835
| -25% | -$4.45M | ﹤0.01% | 1040 |
|
|
2025
Q1 | $21.6M | Sell |
537,624
-8,189
| -2% | -$329K | 0.01% | 879 |
|
|
2024
Q4 | $25.7M | Buy |
545,813
+9,366
| +2% | +$441K | 0.01% | 825 |
|
|
2024
Q3 | $29.2M | Buy |
536,447
+132,886
| +33% | +$7.24M | 0.01% | 769 |
|
|
2024
Q2 | $21.9M | Sell |
403,561
-161,735
| -29% | -$8.76M | 0.01% | 827 |
|
|
2024
Q1 | $39.6M | Sell |
565,296
-95,386
| -14% | -$6.69M | 0.01% | 644 |
|
|
2023
Q4 | $55.2M | Sell |
660,682
-470,406
| -42% | -$39.3M | 0.03% | 472 |
|
|
2023
Q3 | $33.3M | Buy |
1,131,088
+10,903
| +1% | +$321K | 0.02% | 609 |
|
|
2023
Q2 | $36.5M | Buy |
1,120,185
+35,541
| +3% | +$1.16M | 0.02% | 614 |
|
|
2023
Q1 | $38.2M | Sell |
1,084,644
-21,396
| -2% | -$753K | 0.02% | 612 |
|
|
2022
Q4 | $50.7M | Sell |
1,106,040
-2,232
| -0.2% | -$102K | 0.03% | 526 |
|
|
2022
Q3 | $53.7M | Buy |
1,108,272
+14,692
| +1% | +$712K | 0.03% | 499 |
|
|
2022
Q2 | $43M | Buy |
1,093,580
+1,708
| +0.2% | +$67.1K | 0.02% | 583 |
|
|
2022
Q1 | $40.2M | Buy |
1,091,872
+52,799
| +5% | +$1.94M | 0.02% | 659 |
|
|
2021
Q4 | $47.4M | Buy |
1,039,073
+39,026
| +4% | +$1.78M | 0.02% | 650 |
|
|
2021
Q3 | $35.7M | Buy |
+1,000,047
| New | +$35.7M | 0.01% | 746 |
|